Page last updated: 2024-11-06

alantolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Alantolactone is a naturally occurring sesquiterpene lactone found in various plants, including Inula helenium (elecampane). It exhibits a range of biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. Research has shown its potential as a therapeutic agent for various conditions such as skin infections, inflammation, and certain types of cancer. The compound's complex structure and diverse biological activities have made it a subject of extensive research, focusing on its synthesis, mechanisms of action, and potential applications. Its importance lies in its potential to contribute to the development of new drugs and therapies.'

alantolactone: allergenic sesquiterpene lactone; crystalline mixture of alantolactones from group of sesquiterpenes; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

alantolactone : A sesquiterpene lactone that is 3a,5,6,7,8,8a,9,9a-octahydronaphtho[2,3-b]furan-2-one bearing two methyl substituents at positions 5 and 8a as well as a methylidene substituent at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID72724
CHEMBL ID136356
CHEBI ID2540
SCHEMBL ID155169
MeSH IDM0045400

Synonyms (66)

Synonym
(3ar,5s,8ar,9ar)-5,8a-dimethyl-3-methylidene-3a,5,6,7,8,8a,9,9a-octahydronaphtho[2,3-b]furan-2(3h)-one
CHEBI:2540 ,
SPECTRUM5_000383
NCI60_042073
SDCCGMLS-0066583.P001
helenin
nsc 93131
4alphah-eudesma-5,11(13)-dien-12-oic acid, 8beta-hydroxy-, gamma-lactone
naphtho(2,3-b)furan-2(3h)-one, 3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylene-, (3ar-(3a alpha,5beta,8a beta,9a alpha))-
nsc 302289
(3ar-(3aalpha,5beta,8abeta,9aalpha))-3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylenenaphtho(2,3-b)furan-2(3h)-one
einecs 208-899-3
SPECTRUM4_001772
SPECTRUM_000297
BSPBIO_003175
NCGC00178225-01
helenine
NSC93131 ,
elecampane camphor
inula camphor
alant camphor
(3ar,5s,8ar,9ar)-5,8a-dimethyl-3-methylene-5,6,7,8,9,9a-hexahydro-3ah-benzo[f]benzofuran-2-one
ai3-31147
naphtho[2,3-b]furan-2(3h)-one, 3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylene-, (3ar,5s,8ar,9ar)-
eupatal
naphtho[2, 3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylene-, [3ar-(3a.alpha.,5.beta.,8a.beta.,9a.alpha.)]-
nsc-93131
4.alpha.h-eudesma-5, 8.beta.-hydroxy-, .gamma.-lactone
C09289
alantolactone
KBIOGR_002284
KBIO3_002395
KBIO2_003345
KBIO2_005913
KBIO2_000777
KBIOSS_000777
SPECTRUM3_001358
SPBIO_000234
SPECTRUM2_000297
SPECTRUM310010
CHEMBL136356 ,
bdbm50096873
LMPR0103190013
NCGC00178225-02
CCG-39639
m7gsn5q1m6 ,
unii-m7gsn5q1m6
EPITOPE ID:119691
AKOS015906135
S8318
SCHEMBL155169
alantolactone [mi]
8.beta.-hydroxy-4.alpha.h-eudesm-5-en-12-oic acid .gamma.-lactone
CS-3595
(3ar,5s,8ar,9ar)-3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylenenaphtho[2,3-b]furan-2(3h)-one
HY-N0038
AC-31414
alantcamphor
alantolactone, >=98% (hplc)
NCGC00178225-05
BS-17042
Q21099633
naphtho[2,3-b]furan-2(3h)-one,3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylene-,(3ar,5s,8ar,9ar)-
(3ar,5s,8ar,9ar)-5,8a-dimethyl-3-methylene-3,3a,6,7,8,8a,9,9a-octahydronaphtho[2,3-b]furan-2(5h)-one
DTXSID90877864
[3ar-(3a alpha,5 beta,8a beta,9a alpha)]-3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylenenaphtho[2,3-b]furan-2(3h)-one

Research Excerpts

Overview

Alantolactone is a sesquiterpene lactone isolated from Inula helenium L. It exerts an anti-tumor effect in a variety of cancer cell lines. Its effect on esophageal cancer, a common malignancy with poor prognosis, remains unclear.

ExcerptReferenceRelevance
"Alantolactone (Ala) is a sesquiterpene lactone that can be isolated from many herbal plants belonging to Asteraceae. "( Alantolactone: A sesquiterpene lactone with diverse pharmacological effects.
Bian, L; Duan, X; Liu, X; Sui, Y; Yang, L; Zhuang, X, 2021
)
3.51
"Alantolactone is a phytochemical from a traditional Chinese medicinal plant with anti-inflammatory activity, but its precise target remains unclear."( Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3-driven inflammatory diseases in mice.
Chen, J; Li, W; Liang, G; Lin, Y; Luo, W; Shao, J; Wang, Y; Xu, H; Zheng, Z, 2023
)
2
"Alantolactone is a sesquiterpene lactone extracted from Inula helenium L. "( Antitumor activity of alantolactone in lung cancer cell lines NCI-H1299 and Anip973.
Cao, X; He, Y; Kong, Y; Liu, J; Xu, Y; Yang, Z, 2019
)
2.27
"Alantolactone (ALA) is a sesquiterpene lactone with potent anti-inflammatory activity. "( Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-κB signaling pathway.
Dou, W; Han, M; Luo, X; Ren, G; Ren, Y; Sun, A; Wang, Z; Yu, Z; Yue, B; Zhang, J, 2019
)
2.28
"Alantolactone (AL) is a natural compound extracted from the roots of Inula Helenium L, which exerts an anti-tumor effect in a variety of cancer cell lines; however, its effect on esophageal cancer, a common malignancy with poor prognosis, remains unclear. "( Inhibition of Growth of Esophageal Cancer by Alantolactone via Wnt/β- Catenin Signaling.
Chen, H; Deng, M; He, M; Hu, Q; Li, T; Liu, H; Lü, M; Luo, G; Shi, L; Wang, Z, 2021
)
2.32
"Alantolactone is a sesquiterpene lactone isolated from Inula helenium L. "( Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway.
Bu, W; Chen, J; Cui, L; Ding, W; Feng, L; Hou, J; Jia, X; Jiang, Z; Li, C; Liu, D; Luo, Y; Ma, B; Song, J; Wang, C; Wang, J; Xu, T; Yan, H; Yang, L, 2018
)
2.23
"Alantolactone, which is a natural compound produced by Inula helenium, has been shown to induce apoptosis in numerous cancer types."( Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB.
Guo, X; He, R; Li, X; Pan, S; Qin, R; Shi, X; Wang, M; Zhao, C; Zhao, Y; Zhou, M, 2018
)
2.64
"Alantolactone (ALA) is a major bioactive sesquiterpene lactone present in the roots of Inula helenium L. "( High body clearance and low oral bioavailability of alantolactone, isolated from Inula helenium, in rats: extensive hepatic metabolism and low stability in gastrointestinal fluids.
Cho, HJ; Chun, J; Chung, SJ; Kim, DD; Kim, SB; Kim, YS; Lee, JY; Song, KH; Yoon, IS, 2016
)
2.13

Effects

ExcerptReferenceRelevance
"Alantolactone (ATL) has a wide range of pharmacological activities, and its anti-tumor effect is receiving increasing attention."( Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Cheng, W; Feng, L; Hou, Q; Huo, X; Lan, Y; Ma, X; Sun, C; Sun, D; Tian, X; Wang, C; Wang, X; Wang, Y; Xing, J; Yu, Z; Zhang, B, 2017
)
2.62
"Alantolactone (ATL) has a wide range of pharmacological activities, and its anti-tumor effect is receiving increasing attention."( Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Cheng, W; Feng, L; Hou, Q; Huo, X; Lan, Y; Ma, X; Sun, C; Sun, D; Tian, X; Wang, C; Wang, X; Wang, Y; Xing, J; Yu, Z; Zhang, B, 2017
)
2.62

Treatment

Alantolactone treatment resulted in obvious apoptosis in both imatinib-sensitive and -resistant K562 cells, as shown by the increase in Annexin V-positive cells, caspase-3 activation, poly(ADP-ribose) polymerase-1 (PARP-1) cleavage and mitochondrial membrane potential collapse. AlantolActone treatment of HepG2 cells resulted in a dose-dependent induction of apoptosis and arrest of cells in G2-M phase.

ExcerptReferenceRelevance
"Alantolactone treatment resulted in obvious apoptosis in both imatinib-sensitive and -resistant K562 cells, as shown by the increase in Annexin V-positive cells, caspase-3 activation, poly(ADP-ribose) polymerase-1 (PARP-1) cleavage and mitochondrial membrane potential collapse."( Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion.
Chen, L; Huang, H; Li, JM; Liu, CX; Liu, W; Wei, W; Wu, YL; Yan, H; Zhao, S, 2013
)
2.55
"Alantolactone treatment of RKO cells was found to result in dose‑dependent inhibition of cell viability and induction of apoptosis, accompanied with the accumulation of reactive oxygen species (ROS) and the disruption of mitochondrial membrane potential."( Alantolactone induces apoptosis in RKO cells through the generation of reactive oxygen species and the mitochondrial pathway.
Bao, YL; Huang, YX; Li, YX; Sun, Y; Wu, Y; Yu, CL; Zhang, Y; Zheng, LH, 2013
)
2.55
"Alantolactone treatment of HepG2 cells resulted in a dose-dependent induction of apoptosis and arrest of cells in G2-M phase."( Alantolactone induces activation of apoptosis in human hepatoma cells.
Lei, JC; Liu, YW; Yin, Y; Yu, JQ; Zou, GL, 2012
)
2.54
"Alantolactone treatment inhibited the translocation of NF-κB into nucleus; however, NF-κB inhibitor, SN50 failed to potentiate alantolactone-induced apoptosis indicating that alantolactone induces NF-κB-independent apoptosis in glioma cells."( Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Gao, H; Gao, R; Khan, M; Li, T; Ma, T; Rasul, A; Wang, N; Yi, F, 2012
)
2.54

Toxicity

ExcerptReferenceRelevance
"Alantolactone, an allergenic sesquiterpene lactone, is toxic to leukocytes in in vitro cultures."( Toxic effect of alantolactone and dihydroalantolactone in in vitro cultures of leukocytes.
Brisson, J; Dupuis, G, 1976
)
2.04

Pharmacokinetics

ExcerptReferenceRelevance
" The method was successfully applied to pharmacokinetic studies of the two structural isomers after an intravenous injection of Inula helenium formulation to rats."( Simultaneous determination of sesquiterpene lactones isoalantolactone and alantolactone isomers in rat plasma by liquid chromatography with tandem mass spectrometry: application to a pharmacokinetic study.
Guo, C; Niu, K; Teng, S; Zhang, S, 2014
)
0.65
" The pharmacologic activities of alantolactone have been well characterized, yet information on the physicochemical and pharmacokinetic properties of alantolactone and their mechanistic elucidation are still limited."( High body clearance and low oral bioavailability of alantolactone, isolated from Inula helenium, in rats: extensive hepatic metabolism and low stability in gastrointestinal fluids.
Cho, HJ; Chun, J; Chung, SJ; Kim, DD; Kim, SB; Kim, YS; Lee, JY; Song, KH; Yoon, IS, 2016
)
0.97

Bioavailability

ExcerptReferenceRelevance
" Moreover, high total body clearance (111 ± 41 ml/min/kg) and low oral bioavailability (0."( High body clearance and low oral bioavailability of alantolactone, isolated from Inula helenium, in rats: extensive hepatic metabolism and low stability in gastrointestinal fluids.
Cho, HJ; Chun, J; Chung, SJ; Kim, DD; Kim, SB; Kim, YS; Lee, JY; Song, KH; Yoon, IS, 2016
)
0.68
" However, they have been found to have poor oral bioavailability in rats."( Intestinal Absorption of Isoalantolactone and Alantolactone, Two Sesquiterpene Lactones from Radix Inulae, Using Caco-2 Cells.
Li, X; Peng, Y; Wang, M; Xu, R, 2019
)
0.81
" Since low intestinal absorption can now be ruled out as a cause, further studies are needed to explain the low oral bioavailability of the two sesquiterpene lactones."( Intestinal Absorption of Isoalantolactone and Alantolactone, Two Sesquiterpene Lactones from Radix Inulae, Using Caco-2 Cells.
Li, X; Peng, Y; Wang, M; Xu, R, 2019
)
0.81
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds."( High-content single-cell drug screening with phosphospecific flow cytometry.
Clutter, MR; Crane, JM; Krutzik, PO; Nolan, GP, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
sesquiterpene lactoneAny member of a diverse class of complex, multicyclic phytochemicals showing a variety of skeleton arrangements and bioactivities, and having in common a sesquiterpenoid structure including a lactone ring.
naphthofuran
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transcriptional activator MybGallus gallus (chicken)IC50 (µMol)23.64960.62522.76989.5499AID746038
Poly [ADP-ribose] polymerase 1Homo sapiens (human)IC50 (µMol)10.00000.00020.81239.8100AID1862317
UDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12IC50 (µMol)50.00000.10004.21698.8000AID276339
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (63)

Processvia Protein(s)Taxonomy
regulation of gene expressionTranscriptional activator MybGallus gallus (chicken)
mitotic cell cycleTranscriptional activator MybGallus gallus (chicken)
positive regulation of transcription by RNA polymerase IITranscriptional activator MybGallus gallus (chicken)
DNA damage responsePoly [ADP-ribose] polymerase 1Homo sapiens (human)
mitochondrion organizationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
mitochondrial DNA metabolic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of protein localizationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to oxidative stressPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein modification processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
mitochondrial DNA repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIPoly [ADP-ribose] polymerase 1Homo sapiens (human)
telomere maintenancePoly [ADP-ribose] polymerase 1Homo sapiens (human)
DNA repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
double-strand break repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
transcription by RNA polymerase IIPoly [ADP-ribose] polymerase 1Homo sapiens (human)
apoptotic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
DNA damage responsePoly [ADP-ribose] polymerase 1Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayPoly [ADP-ribose] polymerase 1Homo sapiens (human)
response to gamma radiationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of cardiac muscle hypertrophyPoly [ADP-ribose] polymerase 1Homo sapiens (human)
carbohydrate biosynthetic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein autoprocessingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
signal transduction involved in regulation of gene expressionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
macrophage differentiationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
DNA ADP-ribosylationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of DNA-templated transcription, elongationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to insulin stimulusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of intracellular estrogen receptor signaling pathwayPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of transcription elongation by RNA polymerase IIPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to UVPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
innate immune responsePoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of circadian sleep/wake cycle, non-REM sleepPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of innate immune responsePoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of DNA-templated transcriptionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPoly [ADP-ribose] polymerase 1Homo sapiens (human)
decidualizationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of catalytic activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of mitochondrial depolarizationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of SMAD protein signal transductionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of necroptotic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein poly-ADP-ribosylationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein auto-ADP-ribosylationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein localization to chromatinPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to zinc ionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
replication fork reversalPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of cGAS/STING signaling pathwayPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of protein localization to nucleusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of single strand break repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
response to aldosteronePoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of adipose tissue developmentPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of telomere maintenance via telomere lengtheningPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to amyloid-betaPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of myofibroblast differentiationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of base-excision repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of double-strand break repair via homologous recombinationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to nerve growth factor stimulusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
ATP generation from poly-ADP-D-ribosePoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of ATP biosynthetic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
peptidoglycan biosynthetic processUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
regulation of cell shapeUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
peptidoglycan biosynthetic processUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
UDP-N-acetylgalactosamine biosynthetic processUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
cell divisionUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
cell wall organizationUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
protein bindingTranscriptional activator MybGallus gallus (chicken)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscriptional activator MybGallus gallus (chicken)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscriptional activator MybGallus gallus (chicken)
DNA bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
chromatin bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
damaged DNA bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
RNA bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+ ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
zinc ion bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleotidyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
enzyme bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein kinase bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nuclear estrogen receptor bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleosome bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
ubiquitin protein ligase bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
identical protein bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein homodimerization activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
histone deacetylase bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
R-SMAD bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD DNA ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
transcription regulator activator activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein-serine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+- protein-aspartate ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein-glutamate ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein-tyrosine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein-histidine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-histone H2BS6 serine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-histone H3S10 serine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
UDP-N-acetylglucosamine 1-carboxyvinyltransferase activityUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
transferase activityUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
nucleoplasmTranscriptional activator MybGallus gallus (chicken)
nucleusTranscriptional activator MybGallus gallus (chicken)
nucleusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cytosolPoly [ADP-ribose] polymerase 1Homo sapiens (human)
site of double-strand breakPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nuclear replication forkPoly [ADP-ribose] polymerase 1Homo sapiens (human)
site of DNA damagePoly [ADP-ribose] polymerase 1Homo sapiens (human)
chromosome, telomeric regionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nuclear envelopePoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleoplasmPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleolusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
mitochondrionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
membranePoly [ADP-ribose] polymerase 1Homo sapiens (human)
nuclear bodyPoly [ADP-ribose] polymerase 1Homo sapiens (human)
site of double-strand breakPoly [ADP-ribose] polymerase 1Homo sapiens (human)
site of DNA damagePoly [ADP-ribose] polymerase 1Homo sapiens (human)
chromatinPoly [ADP-ribose] polymerase 1Homo sapiens (human)
transcription regulator complexPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein-containing complexPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein-DNA complexPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleolusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cytoplasmUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
cytosolUDP-N-acetylglucosamine 1-carboxyvinyltransferaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (35)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID642415Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID625544Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 30 mins before LPS challenge measured 24 hrs after LPS challenge by Griess reaction method2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Sesquiterpene lactones from Inula falconeri, a plant endemic to the Himalayas, as potential anti-inflammatory agents.
AID95128Effect on cell cycle distribution of K562 cells following treatment of 10 x IC50 for 16 hours and percentage of apoptotic cells (cells with DNA content less than cells in G1 phase) was reported.2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Cytotoxic Michael-type amine adducts of alpha-methylene lactones alantolactone and isoalantolactone.
AID276339Inhibition of Escherichia coli K12 Mur A in presence of UNAG2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
AID495065Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID1862317Inhibition of human recombinant PARP1 in presence of NAD+ by ELISA2022European journal of medicinal chemistry, Oct-05, Volume: 240Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone.
AID735827Antiproliferative activity against human HT1080 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Structural investigation and biological activity of sesquiterpene lactones from the traditional Chinese herb Inula racemosa.
AID495066Inhibition of anisomycin-induced p38 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID95134Effect on cell cycle distribution of K562 cells following treatment of 10 x IC50 for 16 hours and c.v. value was reported.2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Cytotoxic Michael-type amine adducts of alpha-methylene lactones alantolactone and isoalantolactone.
AID625545Cytotoxicity against mouse RAW264.7 cells at antiinflammatory IC50 level by MTT assay2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Sesquiterpene lactones from Inula falconeri, a plant endemic to the Himalayas, as potential anti-inflammatory agents.
AID95132In vitro inhibitory activity against K562 human leukemia cell line2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Cytotoxic Michael-type amine adducts of alpha-methylene lactones alantolactone and isoalantolactone.
AID735828Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Structural investigation and biological activity of sesquiterpene lactones from the traditional Chinese herb Inula racemosa.
AID735826Antiproliferative activity against human HUVEC assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Structural investigation and biological activity of sesquiterpene lactones from the traditional Chinese herb Inula racemosa.
AID95130Effect on cell cycle distribution of K562 cells following treatment of 10 x IC50 for 16 hours and percentage of cells in G2/M phase was reported.2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Cytotoxic Michael-type amine adducts of alpha-methylene lactones alantolactone and isoalantolactone.
AID746037Cytotoxicity against chicken HD11 cells assessed as cell viability after 24 hrs by MTS assay2013European journal of medicinal chemistry, May, Volume: 63Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
AID746038Inhibition of c-Myb-induced mim-1 gene expression in doxycyclin-treated chicken HD11 cells after 24 hrs by GFP assay2013European journal of medicinal chemistry, May, Volume: 63Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
AID642414Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID95133Effect on cell cycle distribution of K562 cells following treatment of 10 x IC50 for 16 hours and percentage of cells in S phase was reported.2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Cytotoxic Michael-type amine adducts of alpha-methylene lactones alantolactone and isoalantolactone.
AID276340Inhibition of Pseudomonas aeruginosa PAO1293 MurA in presence of UNAG2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
AID1407213Inhibition of TGF-beta1/smad3 signaling pathway in mouse NIH/3T3 cells at 10 uM after 18 hrs by CAGA-luciferase reporter gene assay relative to control2018European journal of medicinal chemistry, Sep-05, Volume: 157Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-β1 pathway.
AID276341Inhibition of Escherichia coli K12 Mur A C115D at 50 uM in presence of UNAG2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
AID95131Evaluated for the effect on cell cycle distribution of K562 cells following treatment of 10 x IC50 for 16 hours and percentage of cells in G1 phase was reported.2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Cytotoxic Michael-type amine adducts of alpha-methylene lactones alantolactone and isoalantolactone.
AID735825Antiangiogenic activity against human HUVEC assessed as inhibition of endothelial cell tube formation at 1 ug/ml after 22 hrs by Matrigel assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Structural investigation and biological activity of sesquiterpene lactones from the traditional Chinese herb Inula racemosa.
AID495064Inhibition of JAK-mediated GM-CSF-induced Stat5 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID735829Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by CCK8 assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Structural investigation and biological activity of sesquiterpene lactones from the traditional Chinese herb Inula racemosa.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (122)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (9.02)18.7374
1990's7 (5.74)18.2507
2000's6 (4.92)29.6817
2010's64 (52.46)24.3611
2020's34 (27.87)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.37 (24.57)
Research Supply Index4.85 (2.92)
Research Growth Index5.63 (4.65)
Search Engine Demand Index69.20 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.15%)6.00%
Case Studies4 (3.15%)4.05%
Observational0 (0.00%)0.25%
Other119 (93.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]